Is This Value Stock a Buy?
High-quality dividend stocks tend to hold up the best in turbulent markets. This was recently demonstrated by the health insurer Humana (NYSE: HUM). Its stock has fallen 1% year to date. This is significantly better than the 7% drop in the S&P 500 index thus far.
But is Humana currently a buy for value investors? Let's dive into the stock's fundamentals and valuation to get an answer.
Humana posted healthy revenue and non-GAAP (adjusted) diluted earnings per share (EPS) growth in 2021.
Source Fool.com
